Hospitals evaluating oxygen generator proposals often receive competing
bids from different manufacturers with different technology platforms. How
do you compare a 5th-generation VSA system from one manufacturer against a
3rd-generation PSA system from another when both claim to be 'the best
choice'?
This article provides a technical comparison of LBYL Medical's lithium-VSA
platform against PCI's (Pneumatech/Atlas Copco) 3rd-generation PSA system
across eight engineering parameters, based on publicly available
specifications and thermodynamic principles.
LBYL Medical (founded 1997, Chengdu, China): 28 years in medical gas
engineering, 3,000+ hospital installations, 72 patents including 11
invention patents. 5th-generation VSA platform entered production in 2020.
PCI/Pneumatech (Atlas Copco Group): industrial gas generation heritage,
manufactures PSA oxygen generators for both industrial and medical
markets, widely distributed globally through the Atlas Copco dealer
network.
Parameter 1: Compression Pressure
LBYL VSA: below 0.1 MPa (sub-1 bar). PCI PSA: 0.5-0.75 MPa (5-7.5 bar).
The 5-7.5x compression ratio difference translates to approximately 40-60
percent higher energy consumption per cubic meter in the PSA system.
Parameter 2: Specific Energy Consumption
LBYL VSA: 0.6-1.0 kW/Nm3. PCI PSA: 1.2-2.0 kW/Nm3. At 60 percent average
load factor and 8,760 hours/year, the LBYL system consumes roughly 74,500
fewer kWh annually - approximately $7,450-$18,600/year depending on
electricity rates.
Parameter 3: Molecular Sieve Type and Life
LBYL VSA: Lithium-LSX zeolite, 10+ year life, oil-free environment
preserves sieve integrity. PCI PSA: Sodium or calcium zeolite, 2-3 year
typical life, susceptible to oil contamination degradation. Lithium sieve
eliminates 3-4 replacement events over 10 years.
Parameter 4: Maintenance Burden
LBYL VSA: 6-8 maintenance tasks per year, $4,000-$6,000 annually. PCI PSA:
25-35 maintenance tasks per year, $15,000-$25,000 annually. The PSA
schedule requires 4-5x the labor hours and 3-5x the consumable parts cost.
Parameter 5: System Component Count
LBYL VSA: Integrated rotary assembly combines air compression, nitrogen
exhaust, and cycle timing into a single unit. Approximately 60 percent
fewer components than PSA. PCI PSA: Discrete subsystems with extensive
interconnecting piping and valving. More components equals more potential
failure points.
Parameter 6: Oxygen Recovery Rate
LBYL VSA: 50-65 percent oxygen recovery. PCI PSA: 30-45 percent. Higher
recovery means less air needs to be compressed to produce the same oxygen
output.
Parameter 7: Output Stability Under Varying Load
LBYL VSA: Intelligent control maintains rated efficiency from 30 to 110
percent of design capacity. PCI PSA: Efficiency sweet spot is 60-90
percent of design capacity. Most hospitals operate below peak demand for
80+ percent of operating hours, favoring the LBYL system's wider efficient
range.
Parameter 8: 10-Year Total Cost of Ownership
LBYL VSA 10-year TCO: ~$315,000. PCI PSA 10-year TCO (estimated):
~$647,000. Difference: ~$332,000 in favor of the LBYL VSA platform.
Both manufacturers produce functional, field-proven hospital oxygen
systems. The choice between them is about operating economics and long-
term reliability. The LBYL platform's oil-free design, lower energy
consumption, fewer components, and longer sieve life translate to
significantly lower operating costs. The PCI platform's lower purchase
price offers advantages in procurement convenience.
For a hospital that intends to own and operate the equipment for 10+
years, the operating cost advantage of the LBYL platform is decisive. The
hospitals that get this decision right are the ones where the biomedical
engineering team has a seat at the procurement table and the authority to
explain why purchase price is the wrong way to compare oxygen plants.